Ropes & Gray Adds Experienced FDA Counsel in Washington, D.C.

Global law firm Ropes & Gray today announced that Beth P. Weinman has joined its Washington, D.C. office as counsel in the firm’s life sciences and FDA regulatory practice.

Ms. Weinman previously served as Associate Chief Counsel for Enforcement in the U.S. Food and Drug Administration’s Office of Chief Counsel, where she advised teams of FDA Office of Criminal Investigations agents investigating potential criminal violations of the Federal Food, Drug, and Cosmetic Act and worked with the U.S. Department of Justice to prosecute such matters. She has handled both civil and criminal cases that span various industries and products areas, including those involving drugs, including opioids, drug repackaging and compounding; biologics; medical devices and foods, including dietary supplements.

Her experience encompasses qui tam False Claims Act whistleblower investigations involving the U.S. Department of Health and Human Services, the Department of Justice and other agencies across the federal government. She has also provided counsel on non-qui tam related matters involving issues of off-label promotion and other marketing practices, current good manufacturing practices, and product recalls and withdrawals.

“With experience in private practice and at the FDA, Beth can provide clients with a complete view of FDA regulatory issues,” said Greg Levine, co-chair of Ropes & Gray’s life sciences practice. “Her background is especially valuable to clients who require FDA counseling, as well as compliance advice and assessment of regulatory enforcement risks.”

“Premier life sciences clients turn to Ropes & Gray’s Washington, D.C. office to get access to attorneys who understand life sciences regulatory and enforcement issues,” said Alex Rene, managing partner of Ropes & Gray’s Washington, D.C. office. “Beth’s arrival immediately enhances our offering.”

“Ropes & Gray’s life sciences practice is widely recognized as among the best in the U.S. and I am very excited to bring my understanding of important regulatory issues to clients,” Ms. Weinman said.

Prior to joining the FDA, Ms. Weinman served as a litigation associate in the New York office of an international law firm where she represented pharmaceutical companies in connection with FCA, FDCA and securities related investigations and litigation.

Ms. Weinman received her J.D. from New York University School of Law, where she served as associate editor of the Review of Law and Social Change, and her B.A. in Middle Eastern and Asian Languages and Cultures, magna cum laude, from Columbia College.